Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

702
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
702
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.3K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.3K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.9K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

415
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
415
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

504
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
504

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Marbling Matters: Lean and Fatty Red Meat Show Opposing Associations with Brain Structural Indices.

Nutrients·2026
Same author

Glycoprotein mucin 13 expression as a theranostic target in colorectal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

<i>Escherichia coli</i> pathobionts and Crohn's disease: varied genetic paths leading to similar phenotypes.

Journal of bacteriology·2026
Same author

Initial Evaluation of Feasibility and Cutaneous Toxicity of Electron FLASH Radiotherapy Using a Standard-of-Care Fractionation Scheme in a Porcine Skin Model.

Cancers·2026
Same author

Preclinical Evaluation of Synthetic Biology-Driven Engineered <i>Escherichia coli</i> Nissle 1917 as a Living Therapeutic for Sustained L-DOPA Delivery.

ACS synthetic biology·2026
Same author

Obesity and Insulin Resistance Alter Neural Processing of Unpleasant, but Not Pleasant, Visual Stimuli in Young Adults.

Brain sciences·2026

Related Experiment Video

Updated: Sep 29, 2025

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
07:49

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

Published on: June 2, 2022

3.4K

Clostridioides difficile Infection Dysregulates Brain Dopamine Metabolism.

Akhil A Vinithakumari1, Piyush Padhi2, Belen Hernandez1

  • 1Department of Veterinary Pathology, Iowa State Universitygrid.34421.30, Ames, Iowa, USA.

Microbiology Spectrum
|March 24, 2022
PubMed
Summary

Clostridioides difficile infection (CDI) alters brain dopamine metabolism in mice, potentially impacting neurodevelopmental disorders. This gut pathogen disrupts the gut-brain axis, affecting key neurotransmitter pathways.

Keywords:
Clostridioides difficiledopaminegut-brain axisp-cresol

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

348
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.1K

Related Experiment Videos

Last Updated: Sep 29, 2025

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
07:49

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

Published on: June 2, 2022

3.4K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

348
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.1K

Area of Science:

  • Neuroscience
  • Microbiology
  • Gastroenterology

Background:

  • Gastrointestinal illnesses and dysbiosis are common in neurodevelopmental disorders.
  • The gut-brain axis plays a crucial role in neurologic disease development.

Purpose of the Study:

  • To investigate the impact of Clostridioides difficile infection (CDI) on brain dopamine metabolism.
  • To explore the link between CDI, gut dysbiosis, and neurochemical alterations.

Main Methods:

  • Induction of CDI in mice, predisposed by antibiotic-induced gut dysbiosis.
  • Measurement of dopamine levels and dopamine beta-hydroxylase (DBH) activity in brain regions.
  • Quantification of serum p-cresol concentrations.

Main Results:

  • CDI caused significant alterations in dopamine metabolism in key brain regions.
  • Infected mice showed reduced DBH activity and increased serum p-cresol.
  • P-cresol, a metabolite produced by C. difficile, was identified as a potential DBH inhibitor.

Conclusions:

  • CDI induces significant changes in the brain dopaminergic axis.
  • These alterations may contribute to the precipitation or exacerbation of neurologic diseases.
  • The study suggests a mechanistic link between gut dysbiosis, CDI, and dopamine dysmetabolism.